Haemonetics Corporation (HAE) Financials
HAE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.2 billion | 1.3 billion |
2023-09-30 | 2.0 billion | 1.1 billion |
2023-06-30 | 2.0 billion | 1.1 billion |
2023-03-31 | 1.9 billion | 1.1 billion |
HAE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -22.8 million | 7.2 million |
2023-09-30 | 74.5 million | 6.7 million |
2023-06-30 | 9.4 million | 7.0 million |
2023-03-31 | 67.7 million | 7.1 million |
HAE Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 31.2 million |
2023-09-30 | 24.9 million |
2023-06-30 | 41.0 million |
2023-03-31 | 29.4 million |
HAE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 194.0 million | - | - |
2023-09-30 | 351.0 million | 748.7 million | - |
2023-06-30 | 285.7 million | 751.4 million | - |
2023-03-31 | 284.5 million | 754.1 million | - |
HAE Shares Outstanding
HAE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 22.3 million | 13.3 million | 111.7 million | - |
2023-09-30 | 24.7 million | 12.7 million | 104.9 million | - |
2023-06-30 | 9.7 million | 12.6 million | 93.5 million | - |
2023-03-31 | 11.9 million | 15.6 million | 90.2 million | 7.2 million |
HAE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 336.3 million | 158.4 million |
2023-09-30 | 318.2 million | 147.7 million |
2023-06-30 | 311.3 million | 144.1 million |
2023-03-31 | 304.4 million | 148.2 million |
HAE
Price: $90.99
52 week price:
Earnings Per Share: 2.45 USD
P/E Ratio: 30.65
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 121503
Ebitda: 23.3 millionMarket Capitalization: 4.3 billion